Showing results (201-210 of 225) with videos related to
Sort By:
Pageof 23
The American Journal of Cardiology|April 15, 1993
Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)U Goldbourt, S Behar, H Reicher-Reiss, et al.The American Journal of Medicine|November 3, 2001
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention studyD Tanne, M Benderly, U Goldbourt, et al.American Heart Journal|March 27, 2001
Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era--a national studyA Shotan, S Gottlieb, U Goldbourt, et al.Journal of Clinical Epidemiology|June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) StudyE Barasch, M Benderly, E Graff, et al.Cardiovascular Research|March 1, 1986
Correlation between effects of hydralazine on force and on the adenyl cyclase system of ventricular myocardium in dogs and catsB Rabinowitz, W W Parmley, Y Har-Zahav, et al.Lasers in Surgery and Medicine|January 1, 1988
Carbon dioxide laser effect on platelet function and surface ultrastructure in vitroM Eldar, D Gal, M Djaldetti, et al.Circulation|October 1, 1986
Changes in systemic vascular resistance detected by the arterial resistometer: preliminary report of a new method tested during percutaneous transluminal coronary angioplastyR Mohr, S Rath, O Meir, et al.Circulation|September 1, 1984
The obstructive subaortic conusJ D Waldman, A Schneeweiss, W D Edwards, et al.Journal of the American College of Cardiology|January 1, 1984
Transluminal carbon dioxide-laser catheter angioplasty for dissolution of atherosclerotic plaquesM Eldar, A Battler, H N Neufeld, et al.Hypertension (Dallas, Tex. : 1979)|April 16, 1999
Hypertension in diet versus pharmacologically treated diabetics: mortality over a 5-year follow-upA Tenenbaum, E Z Fisman, V Boyko, et al.Pageof 23